Paper32875673
Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development.
Buckton LK and 2 others. Chemistry, 2021. Cited by 139 papers, by iCite.
Cite this record
ConductScience Library. Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development. Papers, record 32875673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32875673
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Intracellular Space | Major topic |
| Molecular Targeted Therapy | Major topic |
| Peptides, Cyclic | Major topic |
| Cell Membrane Permeability | |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| HBR001 | Frederick Family Foundation | PubMed |
Source PubMed
Cited by77
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 139 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42938089 | Cyclic Peptide PROTACs Restore VHL-Mediated HIF-1α Degradation in Hypoxia. | J Am Chem Soc | 2026 | https://conductscience.org/library/papers/42938089 | PubMed |
| 42893140 | Peptide-Mediated Precise Intracellular Delivery of Bioactive Substances. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42893140 | PubMed |
| 42780127 | Cyclopeptide 161 protects human dermal fibroblasts against UV-induced damage via the MEK1/2-ERK1/2 signaling pathway. | Front Physiol | 2026 | https://conductscience.org/library/papers/42780127 | PubMed |
| 42750055 | Beyond Nature's Blueprint: Macrocyclic Peptides Containing Unnatural Amino Acids in Therapeutic Development. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42750055 | PubMed |
| 42743971 | HighFold4: extending AlphaFold3 to accurate cyclic peptide conformation prediction via custom chemical connectivity. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/42743971 | PubMed |
| 42689447 | Novel Peptide-Triazole Conjugates: Strategic Synthesis, Antimicrobial Properties, and Molecular Docking Study. | J Pept Sci | 2026 | https://conductscience.org/library/papers/42689447 | PubMed |
| 42653761 | Phage Display as a Promising Platform for Peptide Drug Discovery. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42653761 | PubMed |
| 42450332 | Cyclic Peptides as Modulators of Protein-Protein Interactions: A Survival Guide from Discovery Platforms to AI-Driven Design. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450332 | PubMed |
| 42446232 | Hybrid Macrocyclic Peptides - Synthetic Strategies to Diversify and Cyclize Peptide Libraries in Phage Display Selections. | Chemistry | 2026 | https://conductscience.org/library/papers/42446232 | PubMed |
| 42441251 | HFGuidedDesign: de novo design of cyclic peptide binders via structure-guided discrete diffusion. | Chem Sci | 2026 | https://conductscience.org/library/papers/42441251 | PubMed |
| 42371970 | Unified Access to Biaryl-Bridged Linkages Unlocks Structural Diversification of Noncanonical Cyclic Peptides. | J Am Chem Soc | 2026 | https://conductscience.org/library/papers/42371970 | PubMed |
| 42225940 | Generation of membrane-permeable cyclic peptides inhibiting protein-protein interaction. | Nat Chem Biol | 2026 | https://conductscience.org/library/papers/42225940 | PubMed |
| 42131907 | Exploring Passive Permeability Profiles of Cyclic Heptapeptide Chemical Space Uncovers Bioactivity of Mortiamide Scaffold Driven by Colloidal Aggregation. | Chembiochem | 2026 | https://conductscience.org/library/papers/42131907 | PubMed |
| 41982931 | Design of permeability-optimized target-binding macrocycles via direct preference optimization. | Chem Sci | 2026 | https://conductscience.org/library/papers/41982931 | PubMed |
| 41958047 | A Versatile Strategy for Head-to-Tail Macrocyclization and Traceless Backbone Editing of Short Peptides. | J Am Chem Soc | 2026 | https://conductscience.org/library/papers/41958047 | PubMed |
| 41787884 | Macrocyclic Peptides Containing an Imidazopyridinium (IP+) Unit Display Enhanced Passive Cell Permeability. | J Am Chem Soc | 2026 | https://conductscience.org/library/papers/41787884 | PubMed |
| 41523155 | Polyphasic characterization of Biscogniauxia papillata sp. nov. (Graphostromataceae) and isolation of the cytotoxic cyclic pentapeptide cyclobiscognioxin A. | Mycol Prog | 2026 | https://conductscience.org/library/papers/41523155 | PubMed |
| 41502766 | Rational Activity Improvement of Cyclic Peptides through Stabilization and Rigidification of Main Chain Using φ/ψ Plots of Amino Acids. | ACS Omega | 2025 | https://conductscience.org/library/papers/41502766 | PubMed |
| 41479885 | Beyond monoclonal antibodies: constraints and the case for alternative PD-1/PD-L1-targeting formats. | Front Immunol | 2025 | https://conductscience.org/library/papers/41479885 | PubMed |
| 41407967 | An atypical non-ribosomal peptide cyclase catalyzing homochiral coupling with cyclic amine nucleophile. | J Antibiot (Tokyo) | 2026 | https://conductscience.org/library/papers/41407967 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32875673
GET https://conductscience.org/api/papers/v1/32875673/cited_by?page=2